Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist
Keywords: Alzheimer's disease; Neuroinflammation; Amyloid beta; Xamoterol; Beta-1 adrenergic receptor; 5XFAD; 6E10; anti-amyloid beta antibody; AD; Alzheimer's disease; ADRB1, 2, 3; beta1, 2, 3 adrenergic receptors; AT8; anti-phosphorylated tau antibody; AβPP; amy